A detailed history of Executive Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Executive Wealth Management, LLC holds 2,903 shares of ABBV stock, worth $478,965. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,903
Previous 2,903 -0.0%
Holding current value
$478,965
Previous $573,000 -0.0%
% of portfolio
0.05%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $12,779 - $15,547
78 Added 2.76%
2,903 $573,000
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $20,122 - $23,498
130 Added 4.82%
2,825 $484,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $12,306 - $14,021
77 Added 2.94%
2,695 $490,000
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $43,068 - $48,505
313 Added 13.58%
2,618 $405,000
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $33,130 - $38,353
248 Added 12.06%
2,305 $343,000
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $26,236 - $32,650
-198 Reduced 8.78%
2,057 $277,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $5,495 - $6,328
-38 Reduced 1.66%
2,255 $359,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $275,651 - $330,578
1,993 Added 664.33%
2,293 $370,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $260,635 - $298,932
-1,942 Reduced 86.62%
300 $300,000
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $32,891 - $41,815
-239 Reduced 9.63%
2,242 $343,000
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $2,507 - $3,111
-19 Reduced 0.76%
2,481 $402,000
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $8,809 - $11,146
-82 Reduced 3.18%
2,500 $338,000
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $10,959 - $12,440
-103 Reduced 3.84%
2,582 $278,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $22,514 - $25,082
214 Added 8.66%
2,685 $302,000
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $1,023 - $1,126
10 Added 0.41%
2,471 $267,000
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $18,512 - $24,994
230 Added 10.31%
2,461 $263,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $54,351 - $65,346
-863 Reduced 27.89%
2,231 $168,000
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $26,345 - $33,675
-401 Reduced 11.47%
3,094 $225,000
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $82,154 - $96,691
-1,065 Reduced 23.36%
3,495 $282,000
Q4 2018

Feb 19, 2019

BUY
$77.85 - $96.01 $354,996 - $437,805
4,560 New
4,560 $420,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Executive Wealth Management, LLC Portfolio

Follow Executive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Executive Wealth Management, LLC with notifications on news.